Designing clinical trials for brain tumors: the next generation.

Recent clinical trials have demonstrated improvements in survival in patients with malignant gliomas. Laboratory investigations have uncovered genetic alterations that promote gliomagenesis and defined several critical signaling pathways that affect tumor viability, invasiveness, angiogenesis, and resistance to apoptosis. These advances have stimulated… (More)